These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2193445)

  • 1. Severe endothelial injury in a renal transplant patient receiving cyclosporine.
    Fogo A; Hakim RC; Sugiura M; Inagami T; Kon V
    Transplantation; 1990 Jun; 49(6):1190-2. PubMed ID: 2193445
    [No Abstract]   [Full Text] [Related]  

  • 2. Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine.
    Murray BM; Venuto RC; Kohli R; Cunningham EE
    Am J Kidney Dis; 1990 Jul; 16(1):66-9. PubMed ID: 2368707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin for ever?
    Lancet; 1986 Feb; 1(8478):419-20. PubMed ID: 2868342
    [No Abstract]   [Full Text] [Related]  

  • 4. [Duplex sonographic findings following kidney transplantation-- possible value in the diagnosis of graft rejection].
    Gückel C; Lorenz R; Hesse U
    Digitale Bilddiagn; 1988 Jun; 8(2):97-101. PubMed ID: 3042260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma in a renal transplant patient treated with cyclosporine A.
    Messina M; Segoloni GP; Triolo G; Malfi B; Squiccimarro G; Rossetti M; Bernengo MG; Vercellone A
    Nephron; 1987; 45(2):154-5. PubMed ID: 3550499
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
    Tolkoff-Rubin NE; Rubin RH
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity.
    Yoshida M; Kozaki M; Ioya N; Kaji N; Tamaki T; Hiraishi S; Ishii H; Kazama M; Fukutomi K; Nagasawa T
    Transplantation; 1990 Dec; 50(6):1066-9. PubMed ID: 2175057
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prazosin therapy in renal allograft recipients receiving cyclosporine.
    Kiberd BA
    Transplantation; 1990 Jun; 49(6):1200-1. PubMed ID: 2360263
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endothelium.
    Watschinger B; Ulrich W; Vychytil A; Traindl O; Seidl S; Kainz H; Klauser R; Wamser P; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2618-9. PubMed ID: 1465886
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors.
    Lamas S
    Kidney Int; 2005 Aug; 68(2):898-907. PubMed ID: 16014073
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of endothelin immunostaining during rejection episodes after kidney transplantation.
    Watschinger B; Vychytil A; Attar M; Wagner D; Schuller M; Hartter E; Ulrich W
    Clin Nephrol; 1994 Feb; 41(2):86-93. PubMed ID: 8004834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with plasmapheresis in the treatment of vascular rejection following kidney transplantation].
    Eismann R; Konert J; Langkopf B
    Z Urol Nephrol; 1990 Jan; 83(1):9-12. PubMed ID: 2330764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.